Drug discovery today
Oncology pharmaceutical mergers and acquisitions activity in the precision medicine era.
Linjie Wang, Eric Parolin, Zoey Chopra, Garth W Strohbehn
Published: 202510.1016/j.drudis.2025.104578
Abstract
Oncology is the biopharmaceutical industry's most active area for mergers and acquisitions (M&A) activity, reflecting both the scientific innovation and economics of precision medicines in the modern context. This review characterizes trends in 151 p…
Preview only. Read the full abstract at the source